NCT07634471
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07634471
Title A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Acronym MK-1045-007
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | ISR | ESP

Facility Status City State Zip Country Details
SCRI Oncology Partners ( Site 7000) RECRUITING Nashville Tennessee 37203 United States Details
Hadassah Medical Center ( Site 0701) RECRUITING Jerusalem 9112001 Israel Details
Sheba Medical Center ( Site 0702) RECRUITING Ramat Gan 5265601 Israel Details
Sourasky Medical Center ( Site 0704) RECRUITING Tel Aviv 6423906 Israel Details
Hospital Virgen de la Victoria ( Site 0905) RECRUITING Málaga Malaga 29010 Spain Details
Hospital Universitari Vall de Hebron ( Site 0903) RECRUITING Barcelona 08035 Spain Details
Hospital Universitario Gregorio Maranon ( Site 0902) RECRUITING Madrid 28007 Spain Details
Chang Gung Medical Foundation-Linkou Branch ( Site 1002) RECRUITING Taoyuan 333 Taiwan Details
Hacettepe Universite Hastaneleri ( Site 1110) RECRUITING Ankara 06230 Turkey (Türkiye) Details
Sisli Florence Nightingale Hastanesi ( Site 1112) RECRUITING Istanbul 34381 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field